Replimune Group, Inc. (NASDAQ:REPL – Free Report) – Research analysts at Leerink Partnrs dropped their Q1 2025 earnings estimates for shares of Replimune Group in a research report issued on Thursday, May 16th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($0.85) per share for the quarter, down from their previous […]